GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 424 filers reported holding GLOBUS MED INC in Q3 2023. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $179,284,859 | +27.0% | 3,610,974 | +52.3% | 0.01% | +42.9% |
| Q2 2023 | $141,139,391 | +9.1% | 2,370,497 | +3.8% | 0.01% | 0.0% |
| Q1 2023 | $129,408,806 | -60.4% | 2,284,760 | -48.1% | 0.01% | -30.0% |
| Q4 2022 | $327,027,744 | +151.0% | 4,403,228 | +101.3% | 0.01% | +25.0% |
| Q3 2022 | $130,312,000 | +5.7% | 2,187,538 | -0.4% | 0.01% | +14.3% |
| Q2 2022 | $123,314,000 | -24.7% | 2,196,537 | -1.0% | 0.01% | -12.5% |
| Q1 2022 | $163,726,000 | +5.1% | 2,219,112 | +2.9% | 0.01% | +14.3% |
| Q4 2021 | $155,732,000 | -4.0% | 2,156,956 | +1.9% | 0.01% | -22.2% |
| Q3 2021 | $162,206,000 | -1.3% | 2,117,014 | -0.1% | 0.01% | 0.0% |
| Q2 2021 | $164,367,000 | +37.5% | 2,120,046 | +9.4% | 0.01% | +28.6% |
| Q1 2021 | $119,524,000 | -4.8% | 1,938,130 | +0.7% | 0.01% | -12.5% |
| Q4 2020 | $125,500,000 | +36.6% | 1,924,251 | +3.7% | 0.01% | +33.3% |
| Q3 2020 | $91,905,000 | -1.3% | 1,855,916 | -4.9% | 0.01% | -14.3% |
| Q2 2020 | $93,125,000 | -14.0% | 1,951,896 | -23.4% | 0.01% | -22.2% |
| Q1 2020 | $108,338,000 | -27.5% | 2,547,321 | +0.3% | 0.01% | -10.0% |
| Q4 2019 | $149,469,000 | +13.8% | 2,538,538 | -1.2% | 0.01% | 0.0% |
| Q3 2019 | $131,300,000 | +18.0% | 2,568,476 | -2.4% | 0.01% | +25.0% |
| Q2 2019 | $111,285,000 | -12.1% | 2,630,858 | +2.7% | 0.01% | -20.0% |
| Q1 2019 | $126,596,000 | +18.3% | 2,562,146 | +3.6% | 0.01% | 0.0% |
| Q4 2018 | $107,043,000 | -28.8% | 2,473,269 | -6.6% | 0.01% | -16.7% |
| Q3 2018 | $150,306,000 | +19.5% | 2,648,108 | +6.3% | 0.01% | +9.1% |
| Q2 2018 | $125,727,000 | +4.0% | 2,491,589 | +2.7% | 0.01% | +10.0% |
| Q1 2018 | $120,850,000 | +17.6% | 2,425,728 | -2.9% | 0.01% | +25.0% |
| Q4 2017 | $102,723,000 | +41.6% | 2,499,268 | +2.4% | 0.01% | +33.3% |
| Q3 2017 | $72,553,000 | -7.9% | 2,441,251 | +2.7% | 0.01% | -14.3% |
| Q2 2017 | $78,789,000 | +18.4% | 2,376,667 | +5.8% | 0.01% | +16.7% |
| Q1 2017 | $66,545,000 | +23.7% | 2,246,728 | +3.6% | 0.01% | +20.0% |
| Q4 2016 | $53,813,000 | +91.0% | 2,169,124 | +73.8% | 0.01% | +66.7% |
| Q3 2016 | $28,170,000 | +2.5% | 1,248,244 | +8.2% | 0.00% | 0.0% |
| Q2 2016 | $27,493,000 | -1.3% | 1,153,691 | -1.7% | 0.00% | 0.0% |
| Q1 2016 | $27,864,000 | -11.7% | 1,173,144 | +3.5% | 0.00% | 0.0% |
| Q4 2015 | $31,545,000 | +38.3% | 1,133,854 | +2.7% | 0.00% | 0.0% |
| Q3 2015 | $22,814,000 | -19.3% | 1,104,067 | +0.3% | 0.00% | 0.0% |
| Q2 2015 | $28,271,000 | +3.9% | 1,101,238 | +2.2% | 0.00% | 0.0% |
| Q1 2015 | $27,203,000 | +8.9% | 1,077,815 | +2.6% | 0.00% | +50.0% |
| Q4 2014 | $24,983,000 | +23.7% | 1,050,945 | +2.4% | 0.00% | 0.0% |
| Q3 2014 | $20,198,000 | -18.0% | 1,026,683 | -0.3% | 0.00% | -33.3% |
| Q2 2014 | $24,635,000 | -1.2% | 1,029,872 | +9.8% | 0.00% | 0.0% |
| Q1 2014 | $24,939,000 | +21.7% | 937,925 | -13.3% | 0.00% | +200.0% |
| Q4 2013 | $20,493,000 | +35.3% | 1,081,911 | +24.7% | 0.00% | -50.0% |
| Q3 2013 | $15,143,000 | +15.3% | 867,277 | +11.3% | 0.00% | 0.0% |
| Q2 2013 | $13,133,000 | – | 778,951 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 589,100 | $45,137,000 | 24.71% |
| Sterling Investment Advisors, Ltd. | 188,123 | $14,414,000 | 4.29% |
| Godshalk Welsh Capital Management, Inc. | 73,748 | $5,651,000 | 3.52% |
| Pembroke Management, LTD | 601,447 | $46,083,000 | 3.47% |
| Integral Health Asset Management, LLC | 150,000 | $11,493,000 | 3.30% |
| XXEC, Inc. | 51,925 | $3,978,000 | 3.03% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 615,000 | $47,122,000 | 2.42% |
| Van Berkom & Associates Inc. | 946,997 | $72,559,000 | 2.20% |
| RTW INVESTMENTS, LP | 1,670,811 | $128,018,000 | 1.93% |
| Sivik Global Healthcare LLC | 95,000 | $7,279,000 | 1.74% |